Most Active Stories
- Sen. Kelly Ayotte's State Director Resigns Following Prostitution-Related Arrest
- Fish And Game Gets An Earful On Proposed Ban Of Chocolate As Bear Bait
- Winning $146K On 'Jeopardy!' Was N.H. Woman's Lifelong Dream Come True
- Keene City Council Rejects Permit For 2015 Pumpkin Festival
- Far North County To Get More Cell Coverage, High-speed Internet
Wed November 27, 2013
Family Of 12-Year-Old Hudson Girl Seeks FDA Exception For Cancer Drug
U.S. Senator Kelly Ayotte is reaching out to the Food and Drug Administration in an effort to help a Hudson girl with a rare form of brain cancer.
The family of McKenzie Lowe is seeking permission to use an experimental treatment currently banned by the FDA.
In a letter sent this week, Senator Kelly Ayotte urged FDA Commissioner Margaret Hamburg to grant an exception for McKenzie Lowe.
The 12-year-old girl was diagnosed with an inoperable brain tumor a year ago.
Her family wants to use a drug called antineoplastons, which was developed by a controversial Texas physician.
The FDA classifies it as an investigational new drug, meaning is it not available for mainstream use.
Ayotte is among the 42,000 people who have signed an online petition asking the FDA to make a compassionate use exception.
In her letter, Ayotte says the family deserves the right to explore treatment options that may help McKenzie fight her cancer.
According to the family, the FDA has already made several hundred such exemptions for the drug.